REQUEST A DEMO
Total
USD $0.00
Search more companies

PHARMAINVEST Zrt. (Hungary)

Main Activities: Business Support Services
Full name: PHARMAINVEST Zrt. Profile Updated: July 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

PHARMAINVEST Zrt. is based in Hungary. The head office is in Fot. The enterprise operates in the Business Support Services industry. It was established on May 31, 2013. It currently has a total number of 50 (2026) employees. From the latest financial highlights, PHARMAINVEST Zrt. reported a net sales revenue increase of 10.15% in 2025. Its total assets grew by 85.08% over the same period. In 2025, PHARMAINVEST Zrt.’s net profit margin increased by 6.46%.

Headquarters
Szechenyi ter 17.
Fot; Pest; Postal Code: 6720

Contact Details: Purchase the PHARMAINVEST Zrt. report to view the information.

Basic Information
Total Employees:
Purchase the PHARMAINVEST Zrt. report to view the information.
Registered Capital:
Purchase the PHARMAINVEST Zrt. report to view the information.
Financial Auditors:
Purchase the PHARMAINVEST Zrt. report to view the information.
Incorporation Date:
May 31, 2013
Key Executives
Purchase this report to view the information.
Trustee
Purchase this report to view the information.
Trustee
Ownership Details
Purchase this report to view the information.
Subsidiaries
Pingvin Bacs Zrt.
Pingvin Bekes Zrt.
Pingvin Hajdu Zrt.
Company Performance
Financial values in the chart are available after PHARMAINVEST Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.15%
Total Operating Revenue
10.47%
Operating Profit
63.5%
EBITDA
58.23%
Net Profit/Loss for the Period
42.29%
Total Assets
85.08%
Total Equity
41.51%
Operating Profit Margin
10.22%
Net Profit Margin
6.46%
Return on Equity (ROE)
0.54%
Quick Ratio
-1.86%
Cash Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?